ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Classical Swine Fever Vaccines - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-20F405
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Classical Swine Fever Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Classical Swine Fever Vaccines - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-20F405
Report
November 2023
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
WINSUN
CAHIC
Ceva
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Merck
SPAH
Boehringer Ingelheim

Classical Swine Fever Vaccines - Market Size

The global Classical Swine Fever Vaccines market size is expected to reach US$ 211 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029.

Classical Swine Fever Vaccines - Market

Classical Swine Fever Vaccines - Market

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The market is mainly driven by the significant applications of Classical Swine Fever Vaccines in various end use industries. The expanding demands from the Government Tender and Market Sales, are propelling Classical Swine Fever Vaccines market. Tissue Culture Origin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Line Origin segment is estimated at % CAGR for the next seven-year period.
The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 70%, followed by Europe with a market share of about 15%. Tissue Culture Origin is the main type, with a share about 66%. Market Sales is the main application, which holds a share about 95%.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Source, by Sales Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Classical Swine Fever Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Classical Swine Fever Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Classical Swine Fever Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Classical Swine Fever Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Classical Swine Fever Vaccines covered in this report include WINSUN, Merck, CAHIC, Tecon, SPAH, Boehringer Ingelheim, Ceva, Harbin Veterinary Research Institute and Qilu Animal Health Products Factory, etc.
The global Classical Swine Fever Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
WINSUN
Merck
CAHIC
Tecon
SPAH
Boehringer Ingelheim
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP

Scope of Classical Swine Fever Vaccines - Market Report

Report Metric Details
Report Name Classical Swine Fever Vaccines - Market
Forecasted market size in 2029 US$ 211 million
CAGR 4.6%
Forecasted years 2023 - 2029
Global Classical Swine Fever Vaccines market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Classical Swine Fever Vaccines market, Segment by Source:
  • Tissue Culture Origin
  • Cell Line Origin
  • Global Classical Swine Fever Vaccines market, by Sales Channel
  • Government Tender
  • Market Sales
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Source, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Classical Swine Fever Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Sales Channel, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Classical Swine Fever Vaccines - Market size in 2029?

Ans: The Classical Swine Fever Vaccines - Market size in 2029 will be US$ 211 million.

What is the market share of major companies in Classical Swine Fever Vaccines - Market?

Ans: The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share.

1 Classical Swine Fever Vaccines Market Overview
1.1 Classical Swine Fever Vaccines Product Overview
1.2 Classical Swine Fever Vaccines Market Segment by Source
1.2.1 Tissue Culture Origin
1.2.2 Cell Line Origin
1.3 Global Classical Swine Fever Vaccines Market Size by Source
1.3.1 Global Classical Swine Fever Vaccines Market Size Overview by Source (2018-2029)
1.3.2 Global Classical Swine Fever Vaccines Historic Market Size Review by Source (2018-2023)
1.3.3 Global Classical Swine Fever Vaccines Forecasted Market Size by Source (2024-2029)
1.4 Key Regions Market Size Segment by Source
1.4.1 North America Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.2 Europe Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.3 Asia-Pacific Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.4 Latin America Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.5 Middle East and Africa Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
2 Global Classical Swine Fever Vaccines Market Competition by Company
2.1 Global Top Players by Classical Swine Fever Vaccines Sales (2018-2023)
2.2 Global Top Players by Classical Swine Fever Vaccines Revenue (2018-2023)
2.3 Global Top Players by Classical Swine Fever Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Classical Swine Fever Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Classical Swine Fever Vaccines Market Competitive Situation and Trends
2.5.1 Classical Swine Fever Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Classical Swine Fever Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Classical Swine Fever Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Classical Swine Fever Vaccines Market
2.8 Key Manufacturers Classical Swine Fever Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Classical Swine Fever Vaccines Status and Outlook by Region
3.1 Global Classical Swine Fever Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Classical Swine Fever Vaccines Historic Market Size by Region
3.2.1 Global Classical Swine Fever Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Classical Swine Fever Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Classical Swine Fever Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Classical Swine Fever Vaccines Forecasted Market Size by Region
3.3.1 Global Classical Swine Fever Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Classical Swine Fever Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Classical Swine Fever Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Classical Swine Fever Vaccines by Sales Channel
4.1 Classical Swine Fever Vaccines Market Segment by Sales Channel
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Classical Swine Fever Vaccines Market Size by Sales Channel
4.2.1 Global Classical Swine Fever Vaccines Market Size Overview by Sales Channel (2018-2029)
4.2.2 Global Classical Swine Fever Vaccines Historic Market Size Review by Sales Channel (2018-2023)
4.2.3 Global Classical Swine Fever Vaccines Forecasted Market Size by Sales Channel (2024-2029)
4.3 Key Regions Market Size Segment by Sales Channel
4.3.1 North America Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.2 Europe Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.3 Asia-Pacific Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.4 Latin America Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.5 Middle East and Africa Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
5 North America Classical Swine Fever Vaccines by Country
5.1 North America Classical Swine Fever Vaccines Historic Market Size by Country
5.1.1 North America Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
5.2 North America Classical Swine Fever Vaccines Forecasted Market Size by Country
5.2.1 North America Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
6 Europe Classical Swine Fever Vaccines by Country
6.1 Europe Classical Swine Fever Vaccines Historic Market Size by Country
6.1.1 Europe Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Classical Swine Fever Vaccines Forecasted Market Size by Country
6.2.1 Europe Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Classical Swine Fever Vaccines by Region
7.1 Asia-Pacific Classical Swine Fever Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Classical Swine Fever Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Classical Swine Fever Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Classical Swine Fever Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Classical Swine Fever Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Classical Swine Fever Vaccines Sales in Value by Region (2024-2029)
8 Latin America Classical Swine Fever Vaccines by Country
8.1 Latin America Classical Swine Fever Vaccines Historic Market Size by Country
8.1.1 Latin America Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Classical Swine Fever Vaccines Forecasted Market Size by Country
8.2.1 Latin America Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Classical Swine Fever Vaccines by Country
9.1 Middle East and Africa Classical Swine Fever Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Classical Swine Fever Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 WINSUN
10.1.1 WINSUN Company Information
10.1.2 WINSUN Introduction and Business Overview
10.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 WINSUN Classical Swine Fever Vaccines Products Offered
10.1.5 WINSUN Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Classical Swine Fever Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 CAHIC
10.3.1 CAHIC Company Information
10.3.2 CAHIC Introduction and Business Overview
10.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CAHIC Classical Swine Fever Vaccines Products Offered
10.3.5 CAHIC Recent Development
10.4 Tecon
10.4.1 Tecon Company Information
10.4.2 Tecon Introduction and Business Overview
10.4.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Tecon Classical Swine Fever Vaccines Products Offered
10.4.5 Tecon Recent Development
10.5 SPAH
10.5.1 SPAH Company Information
10.5.2 SPAH Introduction and Business Overview
10.5.3 SPAH Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SPAH Classical Swine Fever Vaccines Products Offered
10.5.5 SPAH Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Boehringer Ingelheim Classical Swine Fever Vaccines Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Ceva
10.7.1 Ceva Company Information
10.7.2 Ceva Introduction and Business Overview
10.7.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ceva Classical Swine Fever Vaccines Products Offered
10.7.5 Ceva Recent Development
10.8 Harbin Veterinary Research Institute
10.8.1 Harbin Veterinary Research Institute Company Information
10.8.2 Harbin Veterinary Research Institute Introduction and Business Overview
10.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Products Offered
10.8.5 Harbin Veterinary Research Institute Recent Development
10.9 Qilu Animal Health Products Factory
10.9.1 Qilu Animal Health Products Factory Company Information
10.9.2 Qilu Animal Health Products Factory Introduction and Business Overview
10.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Products Offered
10.9.5 Qilu Animal Health Products Factory Recent Development
10.10 Ringpu Biology
10.10.1 Ringpu Biology Company Information
10.10.2 Ringpu Biology Introduction and Business Overview
10.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ringpu Biology Classical Swine Fever Vaccines Products Offered
10.10.5 Ringpu Biology Recent Development
10.11 DHN
10.11.1 DHN Company Information
10.11.2 DHN Introduction and Business Overview
10.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 DHN Classical Swine Fever Vaccines Products Offered
10.11.5 DHN Recent Development
10.12 CAVAC
10.12.1 CAVAC Company Information
10.12.2 CAVAC Introduction and Business Overview
10.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 CAVAC Classical Swine Fever Vaccines Products Offered
10.12.5 CAVAC Recent Development
10.13 Komipharm
10.13.1 Komipharm Company Information
10.13.2 Komipharm Introduction and Business Overview
10.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Komipharm Classical Swine Fever Vaccines Products Offered
10.13.5 Komipharm Recent Development
10.14 Agrovet
10.14.1 Agrovet Company Information
10.14.2 Agrovet Introduction and Business Overview
10.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Agrovet Classical Swine Fever Vaccines Products Offered
10.14.5 Agrovet Recent Development
10.15 Bioveta
10.15.1 Bioveta Company Information
10.15.2 Bioveta Introduction and Business Overview
10.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Bioveta Classical Swine Fever Vaccines Products Offered
10.15.5 Bioveta Recent Development
10.16 Jinyu Bio-Technology
10.16.1 Jinyu Bio-Technology Company Information
10.16.2 Jinyu Bio-Technology Introduction and Business Overview
10.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Products Offered
10.16.5 Jinyu Bio-Technology Recent Development
10.17 Institutul Pasteur
10.17.1 Institutul Pasteur Company Information
10.17.2 Institutul Pasteur Introduction and Business Overview
10.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Institutul Pasteur Classical Swine Fever Vaccines Products Offered
10.17.5 Institutul Pasteur Recent Development
10.18 MVP
10.18.1 MVP Company Information
10.18.2 MVP Introduction and Business Overview
10.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 MVP Classical Swine Fever Vaccines Products Offered
10.18.5 MVP Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Classical Swine Fever Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Classical Swine Fever Vaccines Industrial Chain Analysis
11.4 Classical Swine Fever Vaccines Market Dynamics
11.4.1 Classical Swine Fever Vaccines Industry Trends
11.4.2 Classical Swine Fever Vaccines Market Drivers
11.4.3 Classical Swine Fever Vaccines Market Challenges
11.4.4 Classical Swine Fever Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Classical Swine Fever Vaccines Distributors
12.3 Classical Swine Fever Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
WINSUN
CAHIC
Ceva
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Merck
SPAH
Boehringer Ingelheim
List of Tables
    Table 1. Major Company of Tissue Culture Origin
    Table 2. Major Company of Cell Line Origin
    Table 3. Global Classical Swine Fever Vaccines Sales by Source 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Classical Swine Fever Vaccines Sales by Source (2018-2023) & (M Doses)
    Table 5. Global Classical Swine Fever Vaccines Sales Market Share in Volume by Source (2018-2023)
    Table 6. Global Classical Swine Fever Vaccines Sales by Source (2018-2023) & (US& Million)
    Table 7. Global Classical Swine Fever Vaccines Market Share in Value by Source (2018-2023)
    Table 8. Global Classical Swine Fever Vaccines Price by Source (2018-2023) & (US$/K Doses)
    Table 9. Global Classical Swine Fever Vaccines Sales by Source (2024-2029) & (M Doses)
    Table 10. Global Classical Swine Fever Vaccines Sales Market Share in Volume by Source (2024-2029)
    Table 11. Global Classical Swine Fever Vaccines Sales by Source (2024-2029) & (US$ Million)
    Table 12. Global Classical Swine Fever Vaccines Sales Market Share in Value by Source (2024-2029)
    Table 13. Global Classical Swine Fever Vaccines Price by Source (2024-2029) & (US$/K Doses)
    Table 14. North America Classical Swine Fever Vaccines Sales by Source (2018-2023) & (M Doses)
    Table 15. North America Classical Swine Fever Vaccines Sales by Source (2018-2023) & (US$ Million)
    Table 16. Europe Classical Swine Fever Vaccines Sales (M Doses) by Source (2018-2023)
    Table 17. Europe Classical Swine Fever Vaccines Sales by Source (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Classical Swine Fever Vaccines Sales (M Doses) by Source (2018-2023)
    Table 19. Asia-Pacific Classical Swine Fever Vaccines Sales by Source (2018-2023) & (US$ Million)
    Table 20. Latin America Classical Swine Fever Vaccines Sales (M Doses) by Source (2018-2023)
    Table 21. Latin America Classical Swine Fever Vaccines Sales by Source (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Classical Swine Fever Vaccines Sales (M Doses) by Source (2018-2023)
    Table 23. Middle East and Africa Classical Swine Fever Vaccines Sales by Source (2018-2023) & (US$ Million)
    Table 24. Global Classical Swine Fever Vaccines Sales by Company (2018-2023) & (M Doses)
    Table 25. Global Classical Swine Fever Vaccines Sales Share by Company (2018-2023)
    Table 26. Global Classical Swine Fever Vaccines Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Classical Swine Fever Vaccines Revenue Share by Company (2018-2023)
    Table 28. Global Market Classical Swine Fever Vaccines Price by Company (2018-2023) & (US$/K Doses)
    Table 29. Global Classical Swine Fever Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Classical Swine Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Classical Swine Fever Vaccines as of 2022)
    Table 32. Date of Key Manufacturers Enter into Classical Swine Fever Vaccines Market
    Table 33. Key Manufacturers Classical Swine Fever Vaccines Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Classical Swine Fever Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Classical Swine Fever Vaccines Sales by Region (2018-2023) & (M Doses)
    Table 37. Global Classical Swine Fever Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Classical Swine Fever Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Classical Swine Fever Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 41. Global Classical Swine Fever Vaccines Sales by Region (2024-2029) & (M Doses)
    Table 42. Global Classical Swine Fever Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Classical Swine Fever Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Classical Swine Fever Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2024-2029)
    Table 46. Global Classical Swine Fever Vaccines Sales by Sales Channel: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) & (M Doses)
    Table 48. Global Classical Swine Fever Vaccines Sales Market Share in Volume by Sales Channel (2018-2023)
    Table 49. Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) & (US$ Million)
    Table 50. Global Classical Swine Fever Vaccines Sales Market Share in Value by Sales Channel (2018-2023)
    Table 51. Global Classical Swine Fever Vaccines Price by Sales Channel (2018-2023) & (US$/K Doses)
    Table 52. Global Classical Swine Fever Vaccines Sales by Sales Channel (2024-2029) & (M Doses)
    Table 53. Global Classical Swine Fever Vaccines Sales Market Share in Volume by Sales Channel (2024-2029)
    Table 54. Global Classical Swine Fever Vaccines Sales by Sales Channel (2024-2029) & (US$ Million)
    Table 55. Global Classical Swine Fever Vaccines Sales Market Share in Value by Sales Channel (2024-2029)
    Table 56. Global Classical Swine Fever Vaccines Price by Sales Channel (2024-2029) & (US$/K Doses)
    Table 57. North America Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) (M Doses)
    Table 58. North America Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) & (US$ Million)
    Table 59. Europe Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) (M Doses)
    Table 60. Europe Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) (M Doses)
    Table 62. Asia-Pacific Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) & (US$ Million)
    Table 63. Latin America Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) (M Doses)
    Table 64. Latin America Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) (M Doses)
    Table 66. Middle East and Africa Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) & (US$ Million)
    Table 67. North America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 68. North America Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Classical Swine Fever Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
    Table 72. North America Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Classical Swine Fever Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 76. Europe Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Classical Swine Fever Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Classical Swine Fever Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
    Table 80. Europe Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Classical Swine Fever Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Classical Swine Fever Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Classical Swine Fever Vaccines Sales by Region (2018-2023) & (M Doses)
    Table 84. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Classical Swine Fever Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Classical Swine Fever Vaccines Sales by Region (2024-2029) & (M Doses)
    Table 88. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Classical Swine Fever Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 92. Latin America Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Classical Swine Fever Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
    Table 96. Latin America Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Classical Swine Fever Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 100. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
    Table 104. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 107. WINSUN Company Information
    Table 108. WINSUN Introduction and Business Overview
    Table 109. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 110. WINSUN Classical Swine Fever Vaccines Product
    Table 111. WINSUN Recent Development
    Table 112. Merck Company Information
    Table 113. Merck Introduction and Business Overview
    Table 114. Merck Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 115. Merck Classical Swine Fever Vaccines Product
    Table 116. Merck Recent Development
    Table 117. CAHIC Company Information
    Table 118. CAHIC Introduction and Business Overview
    Table 119. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 120. CAHIC Classical Swine Fever Vaccines Product
    Table 121. CAHIC Recent Development
    Table 122. Tecon Company Information
    Table 123. Tecon Introduction and Business Overview
    Table 124. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 125. Tecon Classical Swine Fever Vaccines Product
    Table 126. Tecon Recent Development
    Table 127. SPAH Company Information
    Table 128. SPAH Introduction and Business Overview
    Table 129. SPAH Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 130. SPAH Classical Swine Fever Vaccines Product
    Table 131. SPAH Recent Development
    Table 132. Boehringer Ingelheim Company Information
    Table 133. Boehringer Ingelheim Introduction and Business Overview
    Table 134. Boehringer Ingelheim Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 135. Boehringer Ingelheim Classical Swine Fever Vaccines Product
    Table 136. Boehringer Ingelheim Recent Development
    Table 137. Ceva Company Information
    Table 138. Ceva Introduction and Business Overview
    Table 139. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 140. Ceva Classical Swine Fever Vaccines Product
    Table 141. Ceva Recent Development
    Table 142. Harbin Veterinary Research Institute Company Information
    Table 143. Harbin Veterinary Research Institute Introduction and Business Overview
    Table 144. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 145. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product
    Table 146. Harbin Veterinary Research Institute Recent Development
    Table 147. Qilu Animal Health Products Factory Company Information
    Table 148. Qilu Animal Health Products Factory Introduction and Business Overview
    Table 149. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 150. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product
    Table 151. Qilu Animal Health Products Factory Recent Development
    Table 152. Ringpu Biology Company Information
    Table 153. Ringpu Biology Introduction and Business Overview
    Table 154. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 155. Ringpu Biology Classical Swine Fever Vaccines Product
    Table 156. Ringpu Biology Recent Development
    Table 157. DHN Company Information
    Table 158. DHN Introduction and Business Overview
    Table 159. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 160. DHN Classical Swine Fever Vaccines Product
    Table 161. DHN Recent Development
    Table 162. CAVAC Company Information
    Table 163. CAVAC Introduction and Business Overview
    Table 164. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 165. CAVAC Classical Swine Fever Vaccines Product
    Table 166. CAVAC Recent Development
    Table 167. Komipharm Company Information
    Table 168. Komipharm Introduction and Business Overview
    Table 169. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 170. Komipharm Classical Swine Fever Vaccines Product
    Table 171. Komipharm Recent Development
    Table 172. Agrovet Company Information
    Table 173. Agrovet Introduction and Business Overview
    Table 174. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 175. Agrovet Classical Swine Fever Vaccines Product
    Table 176. Agrovet Recent Development
    Table 177. Bioveta Company Information
    Table 178. Bioveta Introduction and Business Overview
    Table 179. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 180. Bioveta Classical Swine Fever Vaccines Product
    Table 181. Bioveta Recent Development
    Table 182. Jinyu Bio-Technology Company Information
    Table 183. Jinyu Bio-Technology Introduction and Business Overview
    Table 184. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 185. Jinyu Bio-Technology Classical Swine Fever Vaccines Product
    Table 186. Jinyu Bio-Technology Recent Development
    Table 187. Institutul Pasteur Company Information
    Table 188. Institutul Pasteur Introduction and Business Overview
    Table 189. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 190. Institutul Pasteur Classical Swine Fever Vaccines Product
    Table 191. Institutul Pasteur Recent Development
    Table 192. MVP Company Information
    Table 193. MVP Introduction and Business Overview
    Table 194. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
    Table 195. MVP Classical Swine Fever Vaccines Product
    Table 196. MVP Recent Development
    Table 197. Key Raw Materials Lists
    Table 198. Raw Materials Key Suppliers Lists
    Table 199. Classical Swine Fever Vaccines Market Trends
    Table 200. Classical Swine Fever Vaccines Market Drivers
    Table 201. Classical Swine Fever Vaccines Market Challenges
    Table 202. Classical Swine Fever Vaccines Market Restraints
    Table 203. Classical Swine Fever Vaccines Distributors List
    Table 204. Classical Swine Fever Vaccines Downstream Customers
    Table 205. Research Programs/Design for This Report
    Table 206. Key Data Information from Secondary Sources
    Table 207. Key Data Information from Primary Sources
List of Figures
    Figure 1. Classical Swine Fever Vaccines Product Picture
    Figure 2. Global Classical Swine Fever Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Classical Swine Fever Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Classical Swine Fever Vaccines Sales Status and Outlook (2018-2029) & (M Doses)
    Figure 5. Product Picture of Tissue Culture Origin
    Figure 6. Global Tissue Culture Origin Sales YoY Growth (2018-2029) & (M Doses)
    Figure 7. Product Picture of Cell Line Origin
    Figure 8. Global Cell Line Origin Sales YoY Growth (2018-2029) & (M Doses)
    Figure 9. Global Classical Swine Fever Vaccines Sales by Source (2018-2029) & (US$ Million)
    Figure 10. Global Classical Swine Fever Vaccines Sales Market Share by Source in 2022 & 2029
    Figure 11. North America Classical Swine Fever Vaccines Sales Market Share in Volume by Source in 2022
    Figure 12. North America Classical Swine Fever Vaccines Sales Market Share in Value by Source in 2022
    Figure 13. Europe Classical Swine Fever Vaccines Sales Market Share in Volume by Source in 2022
    Figure 14. Europe Classical Swine Fever Vaccines Sales Market Share in Value by Source in 2022
    Figure 15. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Volume by Source in 2022
    Figure 16. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Value by Source in 2022
    Figure 17. Latin America Classical Swine Fever Vaccines Sales Market Share in Volume by Source in 2022
    Figure 18. Latin America Classical Swine Fever Vaccines Sales Market Share in Value by Source in 2022
    Figure 19. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share in Volume by Source in 2022
    Figure 20. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share in Value by Source in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Classical Swine Fever Vaccines Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Classical Swine Fever Vaccines Revenue in 2022
    Figure 23. Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Government Tender
    Figure 25. Global Government Tender Sales YoY Growth (2018-2029) & (M Doses)
    Figure 26. Product Picture of Market Sales
    Figure 27. Global Market Sales Sales YoY Growth (2018-2029) & (M Doses)
    Figure 28. Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2029) & (US$ Million)
    Figure 29. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2022 & 2029
    Figure 30. North America Classical Swine Fever Vaccines Sales Market Share in Volume by Sales Channel in 2022
    Figure 31. North America Classical Swine Fever Vaccines Sales Market Share in Value by Sales Channel in 2022
    Figure 32. Europe Classical Swine Fever Vaccines Sales Market Share in Volume by Sales Channel in 2022
    Figure 33. Europe Classical Swine Fever Vaccines Sales Market Share in Value by Sales Channel in 2022
    Figure 34. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Volume by Sales Channel in 2022
    Figure 35. Asia-Pacific Classical Swine Fever Vaccines Sales Market Share in Value by Sales Channel in 2022
    Figure 36. Latin America Classical Swine Fever Vaccines Sales Market Share in Volume by Sales Channel in 2022
    Figure 37. Latin America Classical Swine Fever Vaccines Sales Market Share in Value by Sales Channel in 2022
    Figure 38. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share in Value by Sales Channel in 2022
    Figure 39. Key Raw Materials Price
    Figure 40. Classical Swine Fever Vaccines Manufacturing Cost Structure
    Figure 41. Classical Swine Fever Vaccines Industrial Chain Analysis
    Figure 42. Channels of Distribution
    Figure 43. Distributors Profiles
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions